Feed/Investors/Triwise Capital

Triwise Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-10-27

ROUNDS

as lead investor

LED ROUNDS · USD

$35.0M

across 1 round · 1 co-led, split evenly

LATEST ROUND

Series B · $105.0M · 2026-10-27

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
NeuroXess NeuroXess sells brain-computer interface technology designed to help individuals with severe neurological conditions regain movement and communication capabilities.	Series B Verified against 3 sources	$105.0M	2026-10-27	[ LEAD ]